Skip to main content
Clinical Trials/CTRI/2024/07/071725
CTRI/2024/07/071725
Not yet recruiting
Phase 2

A Comparative Evaluation of Adjuvants with 0.25 percent Bupivacaine in Laparoscopic Guided TAP block: A Double Blind Pilot Study for improved Postoperative Outcomes in Laparoscopic Cholecystectomy - Nil

Gautam Buddha Chikitsa Mahavidyalaya0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
Gautam Buddha Chikitsa Mahavidyalaya
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Gautam Buddha Chikitsa Mahavidyalaya

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists (ASA) physical status I/II patients.
  • \- Age: 18\-60 years of either sex.
  • \- Scheduled for laparoscopic cholecystectomy.
  • \-Patients willing to give written informed consent.

Exclusion Criteria

  • Known allergy to bupivacaine, dexmedetomidine, or clonidine.
  • \- Physical and mental conditions preventing postoperative pain measurement.
  • \- Known coagulopathy.
  • \- Refusal to consent to the procedure.

Outcomes

Primary Outcomes

Not specified

Similar Trials